Incidence of Ischaemic Heart Disease in Men and Women With End-Stage Kidney Disease: A Cohort Study

被引:5
|
作者
O'Lone, Emma [1 ,2 ]
Kelly, Patrick J. [1 ]
Masson, Philip [1 ,2 ]
Kotwal, Sradha [3 ,4 ]
Gallagher, Martin [5 ,6 ]
Cass, Alan [7 ]
Craig, Jonathan C. [8 ]
Webster, Angela C. [1 ,9 ]
机构
[1] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia
[2] Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW, Australia
[3] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia
[4] Prince Wales Hosp, Sydney, NSW, Australia
[5] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
[6] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia
[7] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia
[8] Hinders Univ, Coll Med & Publ Hlth, Adelaide, SA, Australia
[9] Westmead Hosp, Ctr Renal & Transplant Res, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Cardiac disease; Epidemiology; End-stage kidney disease; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; CORONARY-HEART; RENAL-DISEASE; PRIMARY-PREVENTION; RANDOMIZED-TRIALS; SEX-DIFFERENCES; EVENT RATES; TRENDS; RISK;
D O I
10.1016/j.hlc.2020.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The incidence of ischaemic heart disease (IHD) has fallen consistently in the general population; attributed to effective primary prevention strategies. Differences in incidence have been demonstrated by sex. Whether this fall in incidence and sex differences is mirrored in people with end-stage kidney disease (ESKD) is unclear. We aimed to establish the relative risk of H-ID events in the ESKD population. Methods We performed a retrospective cohort study from 2000 to 2010 in people with ESKD in New South Wales. We performed data linkage of the Australia and New Zealand Dialysis and Transplant Registry and state wide hospital admission and death registry data and compared this to general population data. The primary outcome was the incidence rate, incidence rate ratio (IRR), and time-trend for any IHD event. We calculated these using indirect standardisation by IHD event. Results 10,766 participants, contributed 44,149 years of observation time. Incidence rates were substantially higher than the general population for all IHD events (any IHD event: IRR 1.8, 95% confidence interval [CI] 1.7-1.9 for men, IRR 3.4, 95% CI 3.1-3.6 for women). Excess risk was higher in younger people (age 30-49 IRR 4.8, 95% CI 4.2-5.4), and in women with a three-fold increase risk overall and nearly a 10-fold increase in risk in young women (female age 30-49 years: IRR 9.8 95% CI 7.7-12.3), results were similar for angina and acute myocardial infarction. Ischaemic heart disease rates showed some decline for men over time, (ratio of IRR 0.93, 95% CI 0.90-0.95) but were stable for women (ratio of IRR 0.97, 95% CI 0.94-1.01). Conclusions People with ESKD have substantially higher rates of IHD than the general population, especially women, in whom no improvement appears evident over the past 10 years.
引用
收藏
页码:1517 / 1526
页数:10
相关论文
共 50 条
  • [31] Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK
    Gonzalez-Perez, Antonio
    Saez, Maria
    Vizcaya, David
    Lind, Marcus
    Garcia Rodriguez, Luis
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [32] Global case studies for chronic kidney disease/end-stage kidney disease care
    Yang, Chih-Wei
    Harris, David C. H.
    Luyckx, Valerie A.
    Nangaku, Masaomi
    Hou, Fan Fan
    Garcia, Guillermo Garcia
    Abu-Aisha, Hasan
    Niang, Abdou
    Sola, Laura
    Bunnag, Sakarn
    Eiam-Ong, Somchai
    Tungsanga, Kriang
    Richards, Marie
    Richards, Nick
    Goh, Bak Leong
    Dreyer, Gavin
    Evans, Rhys
    Mzingajira, Henry
    Twahir, Ahmed
    McCulloch, Mignon I.
    Ahn, Curie
    Osafo, Charlotte
    Hsu, Hsiang-Hao
    Barnieh, Lianne
    Donner, Jo-Ann
    Tonelli, Marcello
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2020, 10 (01) : E24 - E48
  • [33] Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal disease
    Malik, Mariam E.
    Madelaire, Christian
    D'Souza, Maria
    Blanche, Paul
    Kristensen, Soren L.
    Kistorp, Caroline
    Gustafsson, Finn
    Kober, Lars
    Rorth, Rasmus
    McMurray, John
    Sattar, Naveed
    Gislason, Gunnar
    Torp-Pedersen, Christian
    Schou, Morten
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (05) : 813 - 820
  • [34] A massive natural disaster, the Great East Japan Earthquake, and the incidence of dialysis due to end-stage kidney disease
    Abe, Michiaki
    Akaishi, Tetsuya
    Ishizawa, Koto
    Shinano, Hirohisa
    Ohtomo, Hiroshi
    Orikasa, Kazuhiko
    Takayama, Shin
    Masaura, Atsuko
    Miyazaki, Mariko
    Abe, Takaaki
    Yokota, Kenichi
    Ishii, Tadashi
    JOURNAL OF NEPHROLOGY, 2022, 35 (03) : 719 - 724
  • [35] End of life care in end-stage kidney disease
    Prabhu, Ravindra Attur
    Salins, Naveen
    Bharathi
    Abrahams, Georgi
    INDIAN JOURNAL OF PALLIATIVE CARE, 2021, 27 (05) : 37 - 42
  • [36] Angiographic evaluation of coronary artery disease in diabetic patients with and without end-stage kidney disease
    Gholoobi, Arash
    Ahmadi, Mahnaz
    Ghoraba, Saeed
    Bigdelu, Leila
    Najafi, Mona Najaf
    Rahimi, Vafa Baradaran
    PHYSIOLOGICAL REPORTS, 2024, 12 (15):
  • [37] Association of air pollution with incidence of end-stage kidney disease in two large European cohorts
    Cesaroni, Giulia
    Jaensch, Andrea
    Renzi, Matteo
    Marino, Claudia
    Ferraro, Pietro Manuel
    Kerschbaum, Julia
    Haller, Patrizia
    Brozek, Wolfgang
    Michelozzi, Paola
    Stafoggia, Massimo
    de Hoogh, Kees
    Brunekreef, Bert
    Hoek, Gerard
    Zitt, Emanuel
    Forastiere, Francesco
    Nagel, Gabriele
    Weinmayr, Gudrun
    SCIENCE OF THE TOTAL ENVIRONMENT, 2024, 948
  • [38] Roxadustat increases markers of calcification in patients with end-stage kidney disease: prospective cohort study
    Zhu, Yu-yu
    Zhang, Dan-feng
    Tong, Xiao-wen
    Zhao, Wen-man
    Shi, Rui
    Li, Xun-liang
    Wang, Zhi-juan
    Wang, De-guang
    JOURNAL OF BONE AND MINERAL RESEARCH, 2025, : 492 - 499
  • [39] Obesity as an isolated contraindication to kidney transplantation in the end-stage renal disease population: A cohort study
    Orandi, Babak J.
    Lewis, Cora E.
    MacLennan, Paul A.
    Qu, Haiyan
    Mehta, Shikha
    Kumar, Vineeta
    Sheikh, Saulat S.
    Cannon, Robert M.
    Anderson, Douglas J.
    Hanaway, Michael J.
    Reed, Rhiannon D.
    Killian, A. Cozette
    Purvis, Joshua W.
    Terrault, Norah A.
    Locke, Jayme E.
    OBESITY, 2021, 29 (09) : 1538 - 1546
  • [40] Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis
    Plesner, Louis L.
    Warming, Peder E.
    Nielsen, Ture L.
    Dalsgaard, Morten
    Schou, Morten
    Host, Ulla
    Rydahl, Casper
    Brandi, Lisbet
    Kober, Lars
    Vestbo, Jorgen
    Iversen, Kasper
    HEMODIALYSIS INTERNATIONAL, 2016, 20 (01) : 68 - 77